trending Market Intelligence /marketintelligence/en/news-insights/trending/vgvsmowyxcf7enmcnh-72g2 content esgSubNav
In This List

Memphasys plans 1-for-15 share consolidation

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Memphasys plans 1-for-15 share consolidation

Memphasys Ltd.'s board plans to implement a 1-for-15 share consolidation to make its stock more manageable.

The consolidation will reduce the Australian company's issued share capital to about 340,588,613 ordinary shares from 5,108,829,192 ordinary shares.

Additionally, the number of issued options will be reduced to about 14,998,125 from 224,971,876, the provider of cell and protein separation devices said. The exercise price of these options will also increase by a factor of 15.

Shareholders will vote on the proposal at an Aug. 6 general meeting. Memphasys expects its stock to start trading on a post-consolidation basis Aug. 8.